Loading...
R1 RCM Inc.
RCM•NASDAQ
Healthcare
Medical - Healthcare Information Services
$14.31
$0.00(0.00%)

Financial performance has remained strong, with revenue growing from $575.10M in Q4 2023 to $656.80M in Q3 2024. Gross profit continued to perform well, with margins at 17% in the latest quarter. Operating income reached $15.80M in Q3 2024, holding a steady 2% margin. While R&D and SG&A expenses fluctuated, EBITDA remained robust at $99.00M. Net income dropped to -$19.90M, keeping EPS at -$0.05. With disciplined cost control and operational efficiency, the company supported consistent profitability, reflecting its ability to deliver stable shareholder value.
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan